EUVIMEDEUVIMED entdecken
Editorial

Uncoupling Thrombosis and Hemostasis by Inhibiting Factor XI

Dominick J Angiolillo, Davide Capodanno

New England Journal of Medicine · 23.01.2025 · 392 (4) · 400-403

DOI: 10.1056/nejme2414209 ↗

Kurz gefasst

Editorial in der Zeitschrift New England Journal of Medicine, erschienen am 23.01.2025. Verfasst von Dominick J Angiolillo und 1 weiteren Autor:innen. Beteiligte Einrichtung: From the University of Florida College of Medicine, Jacksonville (D.J.A.); and Azienda Ospedaliero-Universitaria Policlinico "Gaspare Rodolico-San Ma…. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This editorial describes the science behind a clinical trial reported by Ruff et al. in which a monoclonal antibody targeting factors XI and XIa was evaluated for its effects on bleeding events in patients with atrial fibrillation.

Autor:innen und Institutionen

  • From the University of Florida College of Medicine, Jacksonville (D.J.A.); and Azienda Ospedaliero-Universitaria Policlinico "Gaspare Rodolico-San Marco," University of Catania, Catania, Italy (D.C.).

Zitieren

APA

Angiolillo, D. J., & Capodanno, D. (2025). Uncoupling Thrombosis and Hemostasis by Inhibiting Factor XI. New England Journal of Medicine, 392(4), 400-403. https://doi.org/10.1056/nejme2414209

Vancouver

Angiolillo DJ, Capodanno D. Uncoupling Thrombosis and Hemostasis by Inhibiting Factor XI. New England Journal of Medicine. 2025;392(4):400-403. doi:10.1056/nejme2414209

BibTeX
@article{Angiolillo2025,
  author = {Angiolillo, Dominick J and Capodanno, Davide},
  title = {Uncoupling Thrombosis and Hemostasis by Inhibiting Factor XI},
  journal = {New England Journal of Medicine},
  year = {2025},
  volume = {392},
  number = {4},
  pages = {400--403},
  doi = {10.1056/nejme2414209}
}
Kostenlos starten →